Australia · Delayed Price · Currency is AUD Imagion Biosystems Statistics
Total Valuation
ASX:IBX has a market cap or net worth of AUD 4.32 million. The enterprise value is 6.48 million.
| Market Cap | 4.32M |
| Enterprise Value | 6.48M |
Important Dates
The next estimated earnings date is Friday, September 11, 2026.
| Earnings Date | Sep 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ASX:IBX has 539.94 million shares outstanding. The number of shares has increased by 226.41% in one year.
| Current Share Class | 539.94M |
| Shares Outstanding | 539.94M |
| Shares Change (YoY) | +226.41% |
| Shares Change (QoQ) | +38.71% |
| Owned by Insiders (%) | 16.44% |
| Owned by Institutions (%) | 3.27% |
| Float | 386.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.54 |
| PB Ratio | -1.26 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 11.30 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.16
| Current Ratio | 0.16 |
| Quick Ratio | 0.15 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.54 |
| Interest Coverage | -7.62 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -319.68% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 120.00% |
| Weighted Average Cost of Capital (WACC) | 8.53% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.71 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.00% in the last 52 weeks. The beta is -0.23, so ASX:IBX's price volatility has been lower than the market average.
| Beta (5Y) | -0.23 |
| 52-Week Price Change | -50.00% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 35.08 |
| Average Volume (20 Days) | 2,735,870 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ASX:IBX had revenue of AUD 573,231 and -4.63 million in losses. Loss per share was -0.01.
| Revenue | 573,231 |
| Gross Profit | -2.51M |
| Operating Income | -4.10M |
| Pretax Income | -4.63M |
| Net Income | -4.63M |
| EBITDA | -4.10M |
| EBIT | -4.10M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 32,456 in cash and 2.19 million in debt, with a net cash position of -2.16 million or -0.00 per share.
| Cash & Cash Equivalents | 32,456 |
| Total Debt | 2.19M |
| Net Cash | -2.16M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -3.42M |
| Book Value Per Share | -0.01 |
| Working Capital | -3.43M |
Cash Flow
| Operating Cash Flow | -4.05M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 6,370 |
| Net Borrowing | n/a |
| Free Cash Flow | -4.05M |
| FCF Per Share | -0.01 |
Margins
| Gross Margin | n/a |
| Operating Margin | -715.80% |
| Pretax Margin | -807.56% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ASX:IBX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -226.41% |
| Shareholder Yield | -226.41% |
| Earnings Yield | -107.17% |
| FCF Yield | -93.82% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 16, 2023. It was a reverse split with a ratio of 0.025.
| Last Split Date | Nov 16, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.025 |
Scores
ASX:IBX has an Altman Z-Score of -175.95 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -175.95 |
| Piotroski F-Score | 1 |